Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome-Reference-Cited by-同舟云学术

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome

Published:1997-04 Issue:4 Volume:46 Page:454-457
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Velazquez Elsy M.,Mendoza Soaira G.,Wang Ping,Glueck Charles J.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference34 articles.

1. Plasminogen activators and inhibitors;Sprengers;Blood,1987

2. Increased plasma levels of a rapid inhibitor of tissue activator in young survivors of myocardial infarction;Hamsten;N Engl J Med,1985

3. Plasminogen activator inhibitor and other fibrinolytic variables in patients with coronary artery disease;Aznar;Br Heart J,1988

4. Hypofibrinolytic and atherogenic risk factors for stroke;Glueck;J Lab Clin Med,1995

5. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction;Hamsten;Lancet,1987

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin-induced PCSK9 inhibition further decreases LDL-C following statin treatment in patients with coronary artery disease and without diabetes;Journal of Cardiovascular Pharmacology;2024-05-21

2. A novel action of insulin sensitizing drug as a potential promotor of preovulatory follicles, ovulation rate and prolificacy in sheep;Veterinary Research Communications;2023-11-14

3. Lipid profile in girls with precocious puberty: a systematic review and meta-analysis;BMC Endocrine Disorders;2023-10-18

4. A novel action of insulin sensitizing drug as a potential promotor of preovulatory follicles, ovulation rate and prolificacy in sheep: the first exploratory study;2023-08-25

5. Metformin-induced PCSK9 inhibition further decreases LDL-C following statin treatment in non-diabetic patients with coronary artery disease and hyperlipoproteinemia(a);2023-06-14